Commitments and Contingencies - Additional Information (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Product Liability Contingency [Line Items]
Accounts payable and accrued liabilities			$ 100,000
Accounts Payable and Accrued Expense Related Party			67,050
Drug Product Testing Agreement Consideration To Be Paid In Stages	$ 85,000	$ 200,000
Operating Leases, Future Minimum Payments Due	323,000
Other Inventory, Gross	404,378		$ 154,667
Commitments and Contingencies	61,000
First Drug [Member]
Product Liability Contingency [Line Items]
Other Inventory, Gross	404,378
Second Drug [Member]
Product Liability Contingency [Line Items]
Other Inventory, Gross	$ 83,000